We are live on ! Find out more
NPT

Nixon Peabody Trust Portfolio holdings

AUM $1.41B
1-Year Est. Return 27.78%
This Fund
S&P 500
This Quarter Est. Return
+9.05%
1 Year Est. Return
+27.78%
3 Year Est. Return
+85.33%
5 Year Est. Return
+107.3%
10 Year Est. Return
+380.86%
AUM
$260M
AUM Growth
+$12.9M
Cap. Flow
-$6.99M
Cap. Flow %
-2.69%
Top 10 Hldgs %
34.91%
Holding
71
New
1
Increased
16
Reduced
43
Closed
3

Top Buys

Rank Stock Value
1
BLK icon
Blackrock
BLK
+$2M
2
NVS icon
Novartis
NVS
+$207K
3
EW icon
Edwards Lifesciences
EW
+$182K
4
NVDA icon
NVIDIA
NVDA
+$140K
5
DIS icon
Walt Disney
DIS
+$105K

Sector Composition

Rank Sector Weight
1 Technology 22.38%
2 Financials 14.97%
3 Healthcare 13.14%
4 Communication Services 13.01%
5 Consumer Discretionary 10.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EEM icon
51
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$893K 0.34%
16,200
-625
-4% -$34K
SHM icon
52
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.46B
$768K 0.3%
15,500
IWR icon
53
iShares Russell Mid-Cap ETF
IWR
$56B
$660K 0.25%
8,325
IWM icon
54
iShares Russell 2000 ETF
IWM
$79.8B
$559K 0.22%
2,438
-2
-0.1% -$450
XLK icon
55
State Street Technology Select Sector SPDR ETF
XLK
$115B
$428K 0.16%
5,800
BRK.B icon
56
Berkshire Hathaway Class B
BRK.B
$1.1T
$410K 0.16%
1,472
-445
-23% -$124K
JNJ icon
57
Johnson & Johnson
JNJ
$618B
$367K 0.14%
2,231
-150
-6% -$24.8K
XLE icon
58
State Street Energy Select Sector SPDR ETF
XLE
$39.6B
$350K 0.13%
13,000
-17,000
-57% -$442K
ALNY icon
59
Alnylam Pharmaceuticals
ALNY
$27.5B
$339K 0.13%
2,000
MUB icon
60
iShares National Muni Bond ETF
MUB
$45.1B
$331K 0.13%
2,820
AGG icon
61
iShares Core US Aggregate Bond ETF
AGG
$137B
$288K 0.11%
2,500
-182
-7% -$20.9K
APD icon
62
Air Products & Chemicals
APD
$65.7B
$277K 0.11%
964
-582
-38% -$171K
V icon
63
Visa
V
$684B
$267K 0.1%
1,141
-25
-2% -$5.71K
HON icon
64
Honeywell
HON
$77B
$255K 0.1%
1,235
-21
-2% -$4.44K
XLB icon
65
State Street Materials Select Sector SPDR ETF
XLB
$8.5B
$255K 0.1%
6,200
LH icon
66
Labcorp
LH
$25B
$235K 0.09%
989
-146
-13% -$33.3K
IAU icon
67
iShares Gold Trust
IAU
$62.9B
$226K 0.09%
6,714
-1
-0% -$35
EW icon
68
Edwards Lifesciences
EW
$49.6B
$200K 0.08%
+1,934
New +$182K
LIN icon
69
Linde
LIN
$221B
-715
Closed -$200K
TROW icon
70
T. Rowe Price
TROW
$23.9B
-12,822
Closed -$2.2M
UNP icon
71
Union Pacific
UNP
$174B
-1,212
Closed -$267K

Similar funds

Nixon Peabody Trust's Q2 2021 Portfolio in Review

As of Q2 2021, Nixon Peabody Trust held 71 positions worth $260M, up 5.2% from $247M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Nixon Peabody Trust's Q2 2021 filing shows 1 new, 16 increased, 43 reduced and 3 closed positions. Its largest new stake was Edwards Lifesciences: 1,934 shares worth $200K. The largest sale was T. Rowe Price, an estimated $2.2M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • Nixon Peabody Trust's largest Q2 2021 buy was Edwards Lifesciences: 1,934 shares worth $200K.
  • Nixon Peabody Trust added most to Blackrock in Q2 2021, an estimated $2M increase.
  • Nixon Peabody Trust's biggest Q2 2021 reduction was Microsoft, cutting an estimated $949K.
  • Nixon Peabody Trust fully exited T. Rowe Price in Q2 2021, selling an estimated $2.2M.
  • Nixon Peabody Trust's ten largest holdings make up 35% of its $260M portfolio in Q2 2021.
  • Nixon Peabody Trust opened 1 new position and closed 3 in Q2 2021.
  • Nixon Peabody Trust's portfolio value rose 5.2% quarter-over-quarter to $260M.

Based on Nixon Peabody Trust's 13F filing for Q2 2021, filed 30 Jul 2021.